Atle Fund Management AB Diversified Active

Location: Stockholm, Sweden

CIK: 0001381843 · Show all filings

Period: Q4 2013 (Next →)

Filing Date: Feb 5, 2014

Total Value: $101M (100.0% shares, 0.0% debt)

Holdings (18)

Express Scripts Hldg Co 11.8%
Value $11.84M Shares 168,600 Est. Cost $70.24 Unrealized
CRL Charles Riv Labs Intl Inc 11.5%
Value $11.61M Shares 218,900 Est. Cost $50.22 Unrealized 0.0%
Medtronic Inc 11.3%
Value $11.36M Shares 197,900 Est. Cost $57.39 Unrealized
MYGN Myriad Genetics Inc 7.9%
Value $7.935M Shares 378,200 Est. Cost $25.29 Unrealized 0.0%
WellPoint Inc 6.9%
Value $6.975M Shares 75,500 Est. Cost $92.38 Unrealized
Alliance HealthCare Srvcs In 6.9%
Value $6.97M Shares 281,743 Est. Cost $24.74 Unrealized
LifePoint Hospitals Inc 6.9%
Value $6.959M Shares 131,700 Est. Cost $52.84 Unrealized
HOLX Hologic Inc 6.8%
Value $6.816M Shares 304,950 Est. Cost $22.05 Unrealized 0.0%
MCK McKesson Corp 6.8%
Value $6.795M Shares 42,100 Est. Cost $140.55 Unrealized 0.0%
Hill Rom Hldgs Inc 6.7%
Value $6.705M Shares 162,200 Est. Cost $41.34 Unrealized
AORT CryoLife Inc 4.2%
Value $4.192M Shares 378,000 Est. Cost $9.18 Unrealized 0.0%
Skilled Healthcare Group Inc 3.7%
Value $3.693M Shares 767,777 Est. Cost $4.81 Unrealized
Thoratec Corp 3.6%
Value $3.592M Shares 98,135 Est. Cost $36.60 Unrealized
Bard C R Inc 2.9%
Value $2.947M Shares 22,000 Est. Cost $133.95 Unrealized
Cutera Inc 0.9%
Value $877K Shares 86,168 Est. Cost $10.18 Unrealized
Sciclone Pharmaceuticals Inc 0.7%
Value $680K Shares 135,000 Est. Cost $5.04 Unrealized
ICCC ImmuCell Corp 0.3%
Value $297K Shares 69,608 Est. Cost $4.33 Unrealized 0.0%
Chembio Diagnostics Inc 0.3%
Value $281K Shares 83,372 Est. Cost $3.37 Unrealized